AVTX icon

Avalo Therapeutics
AVTX

Overview Fund Activity

65 hedge funds and large institutions have $56.2M invested in Avalo Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 14 closing their positions.

Holders
65
Holders Change
-5
Holders Change %
-7.14%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
25
Closed
14
Calls
$6K
Puts
$12K
Net Calls
-$6K
Net Calls Change
-$49K

Top Buyers

1
AC
1
Armistice Capital
New York
$34.5M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$266K
3
Deutsche Bank
3
Deutsche Bank
Germany
$82K
4
IC
4
Ikarian Capital
Texas
$554K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$987K

Top Sellers

1
SCM
1
Stonepine Capital Management
Oregon
$0
2
SCM
2
Soleus Capital Management
Connecticut
$0
3
IHAM
3
Integral Health Asset Management
New York
$507K
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$31K
5
NCM
5
Nantahala Capital Management
Connecticut
$4.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
Principal Financial Group
76
Principal Financial Group
Iowa
– -$18K -4 Closed
XT
77
XTX Topco
Cayman Islands
– -$20K -4 Closed
ECM
78
ExodusPoint Capital Management
New York
– -$18K -4 Closed
SG Americas Securities
79
SG Americas Securities
New York
– -$17K -4 Closed
Osaic Holdings
80
Osaic Holdings
Arizona
– -$1K – –
1 2 3
4